| Primary |
| Nuclear Magnetic Resonance Imaging |
35.8% |
| Angiogram |
11.8% |
| Nuclear Magnetic Resonance Imaging Brain |
9.8% |
| Arteriogram |
6.9% |
| Product Used For Unknown Indication |
4.9% |
| Chemotherapy |
3.9% |
| Imaging Procedure |
3.4% |
| Pain |
2.5% |
| Scan With Contrast |
2.5% |
| Computerised Tomogram Head |
2.0% |
| Device Related Infection |
2.0% |
| Gastritis Erosive |
2.0% |
| Pseudomonas Infection |
2.0% |
| Supraventricular Tachycardia |
2.0% |
| Venogram |
2.0% |
| Fistulogram |
1.5% |
| Hepatic Cirrhosis |
1.5% |
| Hypercholesterolaemia |
1.5% |
| Nuclear Magnetic Resonance Imaging Abdominal |
1.5% |
| Anxiety |
1.0% |
|
| Anhedonia |
10.8% |
| Nephrogenic Systemic Fibrosis |
10.8% |
| Deformity |
8.1% |
| Skin Induration |
8.1% |
| Abasia |
5.4% |
| Mobility Decreased |
5.4% |
| Pain In Extremity |
5.4% |
| Scar |
5.4% |
| Skin Hyperpigmentation |
5.4% |
| Skin Hypertrophy |
5.4% |
| Skin Tightness |
5.4% |
| Arthralgia |
2.7% |
| Dyspnoea |
2.7% |
| Emotional Distress |
2.7% |
| Fibrosis |
2.7% |
| Hyperhidrosis |
2.7% |
| Joint Stiffness |
2.7% |
| Left Ventricular Dysfunction |
2.7% |
| Muscle Rigidity |
2.7% |
| Musculoskeletal Pain |
2.7% |
|
| Secondary |
| Nuclear Magnetic Resonance Imaging |
40.5% |
| Angiogram |
14.1% |
| Nuclear Magnetic Resonance Imaging Brain |
10.9% |
| Imaging Procedure |
6.5% |
| Product Used For Unknown Indication |
4.0% |
| Pain |
3.2% |
| Chemotherapy |
2.9% |
| Nuclear Magnetic Resonance Imaging Abdominal |
2.3% |
| Venogram |
2.0% |
| Fistulogram |
1.9% |
| Angioplasty |
1.8% |
| Device Related Infection |
1.4% |
| Gastritis Erosive |
1.4% |
| Supraventricular Tachycardia |
1.4% |
| Hypertension |
1.3% |
| Pseudomonas Infection |
1.0% |
| Depression |
0.9% |
| Computerised Tomogram |
0.9% |
| Diabetes Mellitus |
0.9% |
| Anxiety |
0.8% |
|
| Mobility Decreased |
9.0% |
| Anhedonia |
8.3% |
| Oedema Peripheral |
6.9% |
| Skin Plaque |
6.9% |
| Skin Hypertrophy |
6.8% |
| Skin Induration |
6.8% |
| Pain |
5.8% |
| Dry Skin |
5.3% |
| Nephrogenic Systemic Fibrosis |
4.7% |
| Anxiety |
4.6% |
| Skin Fibrosis |
4.2% |
| Emotional Distress |
4.0% |
| Skin Tightness |
4.0% |
| Joint Range Of Motion Decreased |
3.6% |
| Skin Hypopigmentation |
3.6% |
| Joint Contracture |
3.5% |
| Rash |
3.3% |
| Skin Exfoliation |
3.1% |
| Abasia |
2.8% |
| General Physical Health Deterioration |
2.8% |
|
| Concomitant |
| Nuclear Magnetic Resonance Imaging |
40.0% |
| Imaging Procedure |
15.0% |
| Nuclear Magnetic Resonance Imaging Brain |
12.5% |
| Venogram |
10.0% |
| Angiogram |
7.5% |
| Computerised Tomogram |
5.0% |
| Fistulogram |
5.0% |
| Chest Pain |
2.5% |
| Venogram Renal |
2.5% |
|
| Anxiety |
40.0% |
| Scar |
40.0% |
| Fibrosis Tendinous |
20.0% |
|
